{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:01:50Z","timestamp":1793502110657,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd006678","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000}}],"reference-count":50,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006678.pub2","type":"journal-article","created":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T14:42:20Z","timestamp":1420123340000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Chemotherapy for children with medulloblastoma"],"prefix":"10.1002","volume":"2015","author":[{"given":"Erna MC","family":"Michiels","sequence":"first","affiliation":[{"name":"Erasmus MC - Sophia Children's Hospital; Department of Paediatric Oncology; PO Box 2060 Rotterdam Netherlands 3000 CB"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette YN","family":"Schouten-Van Meeteren","sequence":"additional","affiliation":[{"name":"Emma Children's Hospital\/Academic Medical Center; Department of Paediatric Oncology; PO Box 22660 Amsterdam Netherlands 1100 DD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Doz","sequence":"additional","affiliation":[{"name":"Institut Curie; Paediatric Oncology; 26 rue d'Ulm Paris France 75231"},{"name":"University Paris Descartes; Sorbonne Paris Cit\u00e9 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert O","family":"Janssens","sequence":"additional","affiliation":[{"name":"Radboud University Nijmegen Medical Centre; Department of Radiation Oncology; PO Box 9101 Nijmegen Netherlands 6500 HB"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira C","family":"van Dalen","sequence":"additional","affiliation":[{"name":"Emma Children's Hospital\/Academic Medical Center; Department of Paediatric Oncology; PO Box 22660 Amsterdam Netherlands 1100 DD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,1,1]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD006678.pub2-BIB0001|cit1","first-page":"301","article-title":"Medulloblastoma: conventional radiation therapy in comparison to chemoradiation therapy in the post-operative treatment of high-risk patients","volume":"17","author":"Abd El-Aal","year":"2005","journal-title":"Journal of the Egyptian National Cancer Institute"},{"issue":"3","key":"10.1002\/14651858.CD006678.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/mpo.2950250303","article-title":"Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II","volume":"25","author":"Bailey","year":"1995","journal-title":"Medical and Pediatric Oncology"},{"issue":"3","key":"10.1002\/14651858.CD006678.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/mpo.2950250303","article-title":"Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II","volume":"25","author":"Bailey","year":"1995","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1002\/14651858.CD006678.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3171\/jns.1990.72.4.0572","article-title":"The treatment of medulloblastoma: results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone","volume":"72","author":"Evans","year":"1990","journal-title":"Journal of Neurosurgery"},{"key":"10.1002\/14651858.CD006678.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3171\/jns.1991.74.6.0905","article-title":"Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. A Pediatric Oncology Group study","volume":"74","author":"Krischer","year":"1991","journal-title":"Journal of Neurosurgery"},{"issue":"4","key":"10.1002\/14651858.CD006678.pub2-BIB0006|cit6","first-page":"464","article-title":"Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I)","volume":"26","author":"Tait","year":"1990","journal-title":"European Journal of Cancer"},{"issue":"8","key":"10.1002\/14651858.CD006678.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1200\/JCO.2003.05.116","article-title":"Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: the International Society of Paediatric Oncology\/United Kingdom Children's Cancer Study Group PNET-3 study","volume":"21","author":"Taylor","year":"2003","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD006678.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.ijrobp.2003.08.010","article-title":"Impact of radiotherapy parameters on outcome in the international society of paediatric oncology\/United Kingdom children's cancer study group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma","volume":"58","author":"Taylor","year":"2004","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1002\/14651858.CD006678.pub2-BIB0009|cit9","first-page":"681","article-title":"Adjuvant chemotherapy for medulloblastoma and ependymoma using IV vincristine, intrathecal methotrexate, and intrathecal hydrocortisone: a Southwest Oncology Group study","volume":"65","author":"Eys","year":"1981","journal-title":"Cancer Treatment Reports"},{"key":"10.1002\/14651858.CD006678.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/s-2008-1033814","article-title":"Medulloblastoma study of the German Society for Pediatric Oncology, a first report","volume":"194","author":"Neidhardt","year":"1982","journal-title":"Klinische Padiatrie"},{"key":"10.1002\/14651858.CD006678.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1055\/s-2008-1026787","article-title":"Medulloblastoma therapy studies MBL 80 and MED 84 of the Society of Pediatric Oncology and the Soci\u00e9t\u00e9 Internationale d'Oncologie P\u00e9diatrique (SIOP)","volume":"199","author":"Neidhardt","year":"1987","journal-title":"Klinische Padiatrie"},{"key":"10.1002\/14651858.CD006678.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/BF00271125","article-title":"Prospective randomized cooperative medulloblastoma trial (MED 84) of the International Society of Paediatric Oncology (SIOP) and of the (German) Society of Paediatric Oncology (GPO)","volume":"3","author":"Neidhardt","year":"1987","journal-title":"Childs Nervous System"},{"issue":"6","key":"10.1002\/14651858.CD006678.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/pbc.22992","article-title":"Comparison of permanent hair loss in children with standard risk PNETS of the posterior fossa following radiotherapy alone or chemotherapy and radiotherapy after surgical resection","volume":"57","author":"Rogers","year":"2011","journal-title":"Pediatric Blood and Cancer"},{"key":"10.1002\/14651858.CD006678.pub2-BIB0014|cit14","unstructured":"Bloom HJB SIOP medulloblastoma and high grade ependymoma therapeutic clinical trial: preliminary results Proceedings of the XIII meeting of the International Society of Paediatric Oncology (Marseilles) 1981"},{"issue":"10","key":"10.1002\/14651858.CD006678.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/jnen\/59.10.857","article-title":"\"Large cell\/anaplastic\" medulloblastomas: a Pediatric Oncology Group Study","volume":"59","author":"Brown","year":"2000","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"27","key":"10.1002\/14651858.CD006678.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1200\/JCO.2006.08.7684","article-title":"Reduction of health status 7 years after addition of chemotherapy to craniospinal irradiation for medulloblastoma: a follow-up study in PNET3 trial survivors-on behalf of the CCLG (formerly UKCCSG)","volume":"25","author":"Bull","year":"2007","journal-title":"Journal of Clinical Oncology"},{"issue":"11","key":"10.1002\/14651858.CD006678.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1200\/JCO.1999.17.11.3476","article-title":"Neurocognitive development of children after a cerebellar tumor in infancy: a longitudinal study","volume":"17","author":"Copeland","year":"1999","journal-title":"Journal of Clinical Oncology"},{"issue":"31","key":"10.1002\/14651858.CD006678.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"7951","DOI":"10.1200\/JCO.2005.01.5479","article-title":"Beta-catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee","volume":"23","author":"Ellison","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006678.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1470-2045(06)70867-1","article-title":"Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial","volume":"7","author":"Gajjar","year":"2006","journal-title":"Lancet Oncology"},{"issue":"4","key":"10.1002\/14651858.CD006678.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1200\/JCO.2008.18.4176","article-title":"Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma","volume":"27","author":"Gandola","year":"2009","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006678.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"7621","DOI":"10.1200\/JCO.2005.09.095","article-title":"Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group","volume":"23","author":"Geyer","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1002\/14651858.CD006678.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3171\/jns.1999.91.6.0971","article-title":"Medulloblastoma with extensive nodularity: a variant with favorable prognosis","volume":"91","author":"Giangaspero","year":"1999","journal-title":"Journal of Neurosurgery"},{"key":"10.1002\/14651858.CD006678.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1470-2045(05)70252-7","article-title":"Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children","volume":"6","author":"Grill","year":"2005","journal-title":"Lancet Oncology"},{"issue":"5","key":"10.1002\/14651858.CD006678.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1200\/JCO.2000.18.5.1027","article-title":"TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors","volume":"18","author":"Grotzer","year":"2000","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006678.pub2-BIB0025|cit25","first-page":"2425","article-title":"MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor\/medulloblastoma","volume":"7","author":"Grotzer","year":"2001","journal-title":"Clinical Cancer Research"},{"issue":"3","key":"10.1002\/14651858.CD006678.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/cncr.11095","article-title":"Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors","volume":"97","author":"Gurney","year":"2003","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD006678.pub2-BIB0027|cit27","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2005"},{"key":"10.1002\/14651858.CD006678.pub2-BIB0028|cit28","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0","author":"Higgins","year":"2008"},{"issue":"2","key":"10.1002\/14651858.CD006678.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0360-3016(99)00369-7","article-title":"Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT 91","volume":"46","author":"Kortmann","year":"2000","journal-title":"International Journal of Radiation Oncology, Biology and Physics"},{"key":"10.1002\/14651858.CD006678.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0197-2456(00)00046-5","article-title":"Statistical considerations in the intent-to-treat principle","volume":"21","author":"Lachin","year":"2000","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD006678.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/sim.4780101011","article-title":"Analysis of clinical trials by treatment actually received: is it really an option?","volume":"10","author":"Lee","year":"1991","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD006678.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/bjc.1990.138","article-title":"Endocrine disorders following treatment of childhood brain tumours","volume":"61","author":"Livesey","year":"1990","journal-title":"British Journal of Cancer"},{"issue":"3","key":"10.1002\/14651858.CD006678.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ijrobp.2007.07.2342","article-title":"Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma","volume":"70","author":"Merchant","year":"2008","journal-title":"International Journal of Radiation Oncology, Biology and Physics"},{"issue":"11","key":"10.1002\/14651858.CD006678.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1200\/JCO.2009.27.4324","article-title":"Medulloblastoma comprises four distinct molecular variants","volume":"29","author":"Northcott","year":"2011","journal-title":"Journal of Clinical Oncology"},{"issue":"19","key":"10.1002\/14651858.CD006678.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1200\/JCO.2005.00.760","article-title":"Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology study","volume":"23","author":"Oyharcabal-Bourden","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"25","key":"10.1002\/14651858.CD006678.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1200\/JCO.2006.06.4980","article-title":"Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma","volume":"24","author":"Packer","year":"2006","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1002\/14651858.CD006678.pub2-BIB0037|cit37","first-page":"ii8","article-title":"Second malignant neoplasms (SMNS) following \u2018successful\u2019 treatment of non-disseminated medulloblastoma (MB): a 10-year follow-up of patients treated on a COG study","volume":"12","author":"Packer","year":"2010","journal-title":"Neuro-Oncology"},{"issue":"8","key":"10.1002\/14651858.CD006678.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1200\/JCO.2001.19.8.2302","article-title":"Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis","volume":"19","author":"Palmer","year":"2001","journal-title":"Journal of Clinical Oncology"},{"issue":"24","key":"10.1002\/14651858.CD006678.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"10","key":"10.1002\/14651858.CD006678.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1200\/JCO.2008.17.9432","article-title":"Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci","volume":"27","author":"Pfister","year":"2009","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006678.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1023\/B:NEON.0000021774.79094.25","article-title":"High-dose chemotherapy with autologous stem cell rescue as first line of treatment in young children with medulloblastoma and supratentorial primitive neuroectodermal tumors","volume":"67","author":"P\u00e9rez-Martinez","year":"2004","journal-title":"Journal of Neuro-Oncology"},{"key":"10.1002\/14651858.CD006678.pub2-BIB0042|cit42","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2012"},{"key":"10.1002\/14651858.CD006678.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1056\/NEJMoa042176","article-title":"Treatment of early childhood medulloblastoma by postoperative chemotherapy alone","volume":"352","author":"Rutkowski","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006678.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1158\/1078-0432.CCR-06-1779","article-title":"Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91","volume":"13(9)","author":"Rutkowski","year":"2007","journal-title":"Clinical Cancer Research"},{"issue":"33","key":"10.1002\/14651858.CD006678.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1200\/JCO.2010.30.2299","article-title":"Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis","volume":"28","author":"Rutkowski","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006678.pub2-BIB0046|cit46","first-page":"673","article-title":"Endocrine morbidity in adults treated with cerebral irradiation for brain tumours during childhood","volume":"84","author":"Shalet","year":"1977","journal-title":"Acta Endocrinologica"},{"key":"10.1002\/14651858.CD006678.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/mpo.10267","article-title":"Hypothalamo-pituitary-adrenal axis integrity after cranial irradiation for childhood posterior fossa tumours","volume":"40","author":"Spoudeas","year":"2003","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1002\/14651858.CD006678.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00401-011-0922-z","article-title":"Molecular subgroups of medulloblastoma: the current consensus","volume":"123","author":"Taylor","year":"2012","journal-title":"Acta Neuropathologica"},{"issue":"3","key":"10.1002\/14651858.CD006678.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1200\/JCO.1999.17.3.832","article-title":"Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study","volume":"17","author":"Zeltzer","year":"1999","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD006678.pub2-BIB0050|cit50","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006678","article-title":"Chemotherapy for children with medulloblastoma","author":"Michiels","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD006678.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T05:48:11Z","timestamp":1700113691000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006678.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Childhood Cancer Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,1,1]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006678.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,1]]}}}